isosorbide mononitrate

What is isosorbide mononitrate?

Isosorbide mononitrate is a cardiovascular medication primarily prescribed to prevent angina pectoris, a type of chest pain caused by reduced blood flow to the heart. As a nitrate, it works by dilating blood vessels, allowing the heart to pump more efficiently with less strain. Unlike short-acting nitrates used for acute attacks, isosorbide mononitrate is formulated for sustained release, making it ideal for daily prophylaxis in patients with chronic stable angina. It is not intended to treat sudden chest pain episodes.

Key features

• Long-Acting Formula — Provides consistent blood vessel dilation over 12 to 24 hours with once-daily dosing.
• Angina Prevention — Reduces frequency and severity of chest pain in chronic heart conditions.
• Oral Tablet Form — Easy administration with or without food, depending on formulation.
• Controlled Release — Sustained absorption helps maintain stable plasma levels and minimizes rebound effects.
• Prescription-Based — Requires medical supervision due to potential interactions and blood pressure effects.
• Generic Availability — Widely accessible without brand-name pricing.
• Dose Flexibility — Available in multiple strengths to support individualized treatment plans.

Who is isosorbide mononitrate for?

This medication is intended for adults diagnosed with chronic stable angina or ischemic heart disease. It is best suited for those needing long-term prevention of chest pain rather than immediate relief. Patients with a history of heart disease, especially those unable to tolerate beta-blockers or calcium channel blockers, may benefit. It is not recommended for use during acute angina attacks. Use requires physician oversight due to risks of hypotension, headaches, and interactions with PDE5 inhibitors like sildenafil.

How does isosorbide mononitrate compare?

Compared to short-acting nitrates like nitroglycerin, isosorbide mononitrate offers prolonged protection without frequent dosing. It lacks the immediate onset needed for rescue therapy but excels in maintenance. Versus other anti-anginal agents such as beta-blockers or calcium channel blockers, it uniquely targets venous and arterial dilation to reduce cardiac workload. While not a first-line monotherapy in all cases, it's often used in combination regimens. It is more predictable than isosorbide dinitrate due to consistent metabolism and fewer active metabolites.